NextDocs, a software provider helping life science companies run clinical trials more efficiently, has raised $5 million, according to a Form D filing with the U.S. Securities and Exchange Commission. The goal of NextDocs is to help life science companies shift from paper-based to digital documentation and comply with regulators like the U.S. Food and Drug Administration.
It provides a document repository to give customers easy access to trial documentation.
NextDocs has a technology partnership with Microsoft and develops software that’s compatible with Microsoft’s enterprise collaboration software, SharePoint. In a bid to diversify its customer base, NextDocs launched a cloud-based compliance software for emerging life science companies called QuickStart, earlier this year. The software package is intended to help small businesses new to electronic content management rapidly establish a compliance program.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
NextDoc’s fundraise comes two years after it raised more than $10 million in a Series A round from OpenView Venture Partners to help the company’s expansion.
Among the company’s larger clients are Astra Zeneca, McKesson, Sanofi and the National Cancer Center in Japan.